Person with cancer—human epidermal growth factor receptor-2 test type, code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Human epidermal growth factor receptor-2 test type |
Synonymous names: | HER2 test type |
METEOR identifier: | 370607 |
Registration status: | Health, Standard 06/03/2009 |
Definition: | The type of test used to determine the results of human epidermal growth factor receptor-2 (HER2) at the time of diagnosis of the primary tumour, as represented by a code. |
Data element concept attributes | |
Identifying and definitional attributes | |
Data element concept: | Person with cancer—human epidermal growth factor receptor-2 test type |
---|---|
METEOR identifier: | 370582 |
Registration status: | Health, Standard 06/03/2009 |
Definition: | The test used to determine the results of a person's human epidermal growth factor receptor-2 (HER2) at the time of diagnosis of the primary tumour. |
Object class: | Person with cancer |
Property: | Human epidermal growth factor receptor-2 test type |
Value domain attributes | |
Identifying and definitional attributes | |
Value domain: | HER2 test type code N |
---|---|
METEOR identifier: | 370580 |
Registration status: | Health, Standard 06/03/2009 |
Definition: | A code set representing the type of test used to determine the HER2 result. |
Collection and usage attributes | |
Guide for use: | CODE 2 Brightfield in situ hybridisation Includes Chromogenic in situ hybridisation (CISH) and Silver in situ hybridisation (SISH). |
---|
Data element attributes | |
Collection and usage attributes | |
Guide for use: | Record the test type corresponding to the test result recorded in 'Person with Cancer - human epidermal growth factor receptor-2 test result'. |
---|---|
Comments: | Immunochemistry (IHC) measures how much HER2 protein is present in the tumour sample. Fluorescence in situ hybridisation (FISH), chromogenic in situ hybridisation (CISH) and silver in situ hybridisation (SISH) measure the amount of amplification of the gene responsible for HER2. The type of HER2 test used to determine HER2 status affects the accuracy of the information. |
Source and reference attributes | |
Origin: | National Breast and Ovarian Cancer Centre (NBOCC) Australasian Association of Cancer Registries (AACR) Australian Institute of Health and Welfare (AIHW) |
Relational attributes | |
Implementation in Data Set Specifications: | Breast cancer (Cancer registries) DSS Health, Superseded 01/09/2012 Breast cancer (cancer registries) NBPDS Health, Standard 01/09/2012 |
<Title>
<body>
<footer>